---
schema_version: '1.0'
id: news-20260826-e9696d
title: FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
url: https://www.fda.gov/news-events/press-announcements/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer
url_hash: e9696d12e8a331a466029084c2809b85472393a80cf0fea95e2bd7eda9fc4eb2
canonical_url: https://www.fda.gov/news-events/press-announcements/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer
source: HackerNews
category: news/tech
category_raw: tech
region: usa
tags: []
lang: en
published_at: '2026-08-26T16:19:03Z'
fetched_at: '2026-08-26T22:18:34.622655Z'
updated_at: '2026-08-26T22:39:05Z'
status: published
content_hash: bf1b37bff05f803e8e01c633f9e1cd0dfb140773368521a77cd8fc3095b8ddf7
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- Approves
- artificial intelligence
- cancer
- Class
- Classical Computer
- FDA
- First
- First Judicial District Attorneys Office
- for
- Metastatic
- MetastaticPancreaticCancer
- Pancreatic
- Targeted
- technology
- Therapy
entities_en:
- name: cancer
  type: UNKNOWN
- name: Classical Computer
  type: artifact
- name: FDA
  type: organization
- name: First Judicial District Attorneys Office
  type: organization
- name: MetastaticPancreaticCancer
  type: concept
topics_en:
- artificial intelligence
- technology
numeric_facts: []
entities:
- name: FDA
  type: organization
- name: First Judicial District Attorneys Office
  type: organization
- name: Classical Computer
  type: artifact
- name: MetastaticPancreaticCancer
  type: concept
- name: cancer
  type: UNKNOWN
key_facts: []
related: []
related_auto:
- name: Prana Surgical
  type: 組織
  weight: 1.0
- name: ウェアラブルデバイス
  type: artifact
  weight: 1.0
- name: Higashino Keigo
  type: person
  weight: 1.0
computed_at: '2026-08-26T22:38:58Z'
---

# FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- (なし)

## Details
(本文なし。リンク先参照)

## Source
元記事: [FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer](https://www.fda.gov/news-events/press-announcements/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer) — published 2026-08-26T16:19:03Z